Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · IEX Real-Time Price · USD
3.040
-0.160 (-5.00%)
Jul 22, 2024, 10:17 AM EDT - Market open
Aquestive Therapeutics Employees
Aquestive Therapeutics had 135 employees as of December 31, 2023. The number of employees increased by 5 or 3.85% compared to the previous year.
Employees
135
Change (1Y)
5
Growth (1Y)
3.85%
Revenue / Employee
$381,496
Profits / Employee
-$213,081
Market Cap
286.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 815 |
Adaptimmune Therapeutics | 449 |
MeiraGTx Holdings | 425 |
Poseida Therapeutics | 330 |
Akebia Therapeutics | 167 |
Alimera Sciences | 159 |
Prelude Therapeutics | 128 |
Orchestra BioMed Holdings | 56 |
AQST News
- 25 days ago - Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - GlobeNewsWire
- 7 weeks ago - Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire